Your browser doesn't support javascript.
loading
PIMASERTIB AND SEROUS RETINAL DETACHMENTS.
AlAli, Alaa; Bushehri, Ahmad; Park, Jonathan C; Krema, Hatem; Lam, Wai-Ching.
Afiliação
  • AlAli A; Departments of *Ophthalmology and Vision Sciences, and †Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Retin Cases Brief Rep ; 10(2): 191-6, 2016.
Article em En | MEDLINE | ID: mdl-26444523
PURPOSE: To report a case of multifocal serous retinal detachments associated with pimasertib. METHODS: The authors report a 26-year-old patient who developed bilateral multifocal serous retinal detachments appearing 2 days after starting pimasertib (as part of a clinical trial investigating its use in low-grade metastatic ovarian cancer) and rapidly resolving 3 days after stopping it. CONCLUSION: The mechanism of MEK inhibitor induced visual toxicity remains unclear. The pathophysiology of multifocal serous retinal detachments as a complication of pimasertib is still poorly understood.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retina / Descolamento Retiniano / Niacinamida Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Retin Cases Brief Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retina / Descolamento Retiniano / Niacinamida Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Retin Cases Brief Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos